Extracellular vesicles secreted by human mesenchymal stem cells affect cell viability after exposure to amyloid beta oligomers

Authors

  • Olivia Zeng Rickards High School

Keywords:

Human mesenchymal stem cells, extracellular vesicles, amyloid beta 42 oligomers, Alzheimer's disease, cell viability

Abstract

Alzheimer’s disease is a neurodegenerative disorder that causes decreased memory and thinking, eventually to the inability to carry out simple daily tasks. This is due to the increase in destruction of cells. Extracellular vesicles (EVs) secreted by human stem cells for intercellular communications have been known to have therapeutic effects because of their delivery of cargo, which includes the biological macromolecules such as protein and microRNA. In this study, human mesenchymal stem cells (hMSCs) were cultured, and the extracellular vesicles isolated from hMSC media were characterized. Some hMSCs were then treated with amyloid beta 42 oligomers (a hallmark of ALzheimer’s disease) and some contained both amyloid beta 42 oligomers and extracellular vesicles. Then live/dead assay was performed to compare and evaluate the viability of cells with amyloid beta 42 oligomers that were and were not treated with extracellular vesicles. The hypothesis was that hMSC-EVs are able to restore cell viability after exposure to Aβ42. Since there was a noticeable increase in cell viability in cells treated with extracellular vesicles, this study can potentially advance the treatment of Alzheimer’s disease.

Downloads

Download data is not yet available.

References

Amakiri N, Kubosumi A, Tran J, Reddy PH (2019) Amyloid Beta and MicroRNAs in Alzheimer's Disease. Front Neurosci 13:430. https://doi.org/10.3389/fnins.2019.00430.

Breijyeh Z, Karaman R (2020) Comprehensive Review on Alzheimer’s Disease: Causes and Treatment. Molecules, 25, 5789. https://doi.org/10.3390/molecules25245789.

Chen Y and Yu L (2022) Extracellular vesicles: from bench to bedside. Current Medicine 1:3. Cone AS, Yuan X, Sun L, Duke LC, Vreones MP, Carrier AN, Kenyon SM, Carver SR, Benthem SD, Stimmell AC and others. 2021. Mesenchymal stem cell-derived extracellular vesicles ameliorate Alzheimer’s disease-like phenotypes in a preclinical mouse model. Theranostics 11(17):8129-8142. https://doi.org/10.1007/s44194-022-00001-2.

Freshney's Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications 8th Edition by R. Ian Freshney, Amanda Capes-Davis, WileyBlackwell, 2021.

Maturi, Naresh. “Transmission electron microscopy schematic diagram.” Research Gate, November 2013, https://www.researchgate.net/publication/281534044_Vision_and_visual_servoing_for_nanomanipulation_and_nanocharacterization_in_scanning_electron_microscope. Accessed 25 November 2022.

Moore, Michael. “Western Blot Procedures, Analysis and Purpose.” Helvetica Health Care, 11 July 2022, https://www.h-h-c.com/western-blot-procedures-analysis-and-purpose/. Accessed 25 November 2022.

Nagelkerke A, Ojansivu M, van der Koog L, Whittaker TE, Cunnane EM, Silva AM, Dekker N, Stevens MM. (2021) Extracellular vesicles for tissue repair and regeneration: Evidence, challenges and opportunities. Adv Drug Deliv Rev 175:113775. https://doi.org/10.1016/j.addr.2021.04.013.

“RNeasy Pure mRNA Beat Kit Procedure.” Qiagen,https://www.qiagen.com/us/products/discovery-and-translational-research/dna-rna-purification/rna-purification/mrna/rneasy-pure-mrna-bead-kit/. Accessed 25 November 2022.

Terriaca S, Fiorelli E, Scioli MG, Fabbri G, Storti G, Cervelli V, Orlandi A (2021) Endothelial Progenitor Cell-Derived Extracellular Vesicles: Potential Therapeutic Application in Tissue Repair and Regeneration. Int. J. Mol. Sci., 22, 6375. https://doi.org/10.3390/ijms22126375.

Wiklander OPB, Brennan MA, Lotvall J, Breakefield XO, El Andaloussi S (2019) Advances in therapeutic applications of extracellular vesicles. Sci Transl Med 11(492). 10.1126/scitranslmed.aav8521.

Downloads

Published

2023-07-15

How to Cite

Zeng, O. (2023). Extracellular vesicles secreted by human mesenchymal stem cells affect cell viability after exposure to amyloid beta oligomers. International Journal of Life Sciences, 11(2), 133–142. Retrieved from https://ijlsci.in/ls/index.php/home/article/view/782

Issue

Vol. 11 No. 2 (2023): International Journal of Life Sciences

Section

Research Articles

License

Copyright (c) 2023 Olivia Zeng

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license unless indicated otherwise in a credit line to the material. If the material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/ licenses/by/4.0/